FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

985811000001107: Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22573101000001117 Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22573201000001112 Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Is pack of Methylprednisolone acetate+lidocaine hydrochloride 80/20mg/2mL injection false Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Has active ingredient Lidocaine hydrochloride false Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Has active ingredient Methylprednisolone acetate false Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Has active ingredient Methylprednisolone false Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Has active ingredient Lidocaine false Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Has manufactured dose form Conventional release suspension for injection false Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Has VMP Methylprednisolone acetate+lidocaine hydrochloride 80/20mg/2mL injection false Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Has specific active ingredient Methylprednisolone acetate true Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Has dispensed dose form Conventional release suspension for injection true Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Has VMP Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials false Inferred relationship Existential restriction modifier
Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Has VMP Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Depo-Medrone with Lidocaine suspension for injection 2ml vials (Pfizer Ltd) 1 vial Is a True Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Inferred relationship Existential restriction modifier
Depo-Medrone with Lidocaine suspension for injection 2ml vials (Waymade Ltd) 1 vial Is a True Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start